Upkar S. Gill

This study shows that people with HBV/HIV co-infection maintain functional HBV-specific CD4+ T helper responses and coordinated CD4/CD8 antiviral immunity, suggesting preserved antiviral immunity.

This pilot study identifies British South Asians at high risk of cholestatic liver disease through genetic and phenotypic recall, finding 66.7% of participants had undetected liver disease.

This study expands adaptive NKG2C+ NK cells from HBV-infected donors, showing enhanced ADCC and anti-hepatoma activity.

This study finds that auto-antibodies against interferons are common in chronic hepatitis B patients and linked to PegIFN treatment non-response.

This study introduces HBV-CRA, a rapid whole-blood assay that identifies immune profiles associated with HBsAg clearance and reveals heterogeneous T cell responses in chronic hepatitis B patients.

IBRAP is a tool that benchmarks scRNA-seq analysis pipelines by allowing interchangeable methods and metrics to find optimal combinations for different data types and studies.